Our Life Sciences division is led by Peter Dines, who is also Mercia Asset Management PLC’s COO.
Many EIS funds invest in only Software, however we invests across both Software and Life Sciences, and we will explain why we believe a wider technology focused strategy offers benefits.
Peter will discuss the specific subsectors in Life Sciences in which we are currently focusing on, our ability to support companies from an early stage through to realisation, and he will describe how we help the companies along the way.
In addition to outlining various other Life Sciences’ companies in the portfolio, Peter will present a case study of how we have supported Sense Biodetection.
(Capital at Risk. Past performance is not a reliable indicator of future return)